4th Quarter - Termination
FAEGRE BAKER DANIELS CONSULTING for PEAR THERAPEUTICS
Client
Income
$10,000
Expenses
—
Terminated
Oct 31, 2019
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Increase awareness of clinical use of FDA cleared prescription digital therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN KEVIN BRENNAN | Chief of Staff, Rep. Rosa DeLauro (D-CT); Legislative Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA) |
| MEGAN SUSSMAN HERBER | Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA) |
| MATTHEW JEFFREY RUBIN | — |
Medicare/Medicaid MMM
Medicare coverage of FDA cleared prescription digital therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN KEVIN BRENNAN | Chief of Staff, Rep. Rosa DeLauro (D-CT); Legislative Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA) |
| MEGAN SUSSMAN HERBER | Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA) |
| MATTHEW JEFFREY RUBIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.